A teleconference was organised on 26 February 2018 with the SGE LSD Member countries, chaired by the President of the GF-TADs for Europe Dr Bernard Van Goethem. Its objective was to get an update on countries 2018 LSD vaccination plans, the estimated number of vaccine doses needed, the state of play of national procurement, vaccine doses in stock from previous year, doses estimated to be purchased as well as doses to be provided by the EU LSD vaccine bank in 2018.
The European Commission also provided information on the possible EU support for LSD vaccination in 2018 in South Europe (cost-free donations from the EU LSD vaccine bank; reimbursement for the cost of vaccines purchased by national funds and used in 2017).
Dr Van Goethem highlighted the excellent animation on the progress of LSD vaccination in 2016 and 2017 and reported LSD outbreaks in South East Europe done by EFSA demonstrating the efficiency of the GF-TADs coordinated policy of vaccination against LSD in South East Europe (from 1/2016 to 12/2017), using GF-TADs / EU data and financed by the EU. This shows clearly the GF-TADs added value in the animal health area (value for money for Europe).
